login
  Password reminder
Vascular News
Contact the editor Visit Vascular News Twitter feed Visit Vascular News Facebook page
 

ClariVein: New method for vein ablation introduced in Europe


Thursday, 15 Jul 2010 10:23
ClariVein Occlusion Catheter
ClariVein Occlusion Catheter


The ClariVein Occlusion Catheter was introduced at four European medical facilities towards the end of June 2010, with the intention of endovascular occlusion of incompetent veins in patients with superficial venous reflux.


Successful use of the catheter has been reported at Privatklinik Proebstle in Mannheim, Germany and three medical centres in The Netherlands (Antonius Hospital in Nieuwegein, Rijnstate Hospital in Arnhem, and Maastricht University Medical Centre).

 

ClariVein is a non-thermal approach that uses a mechanical rotating dispersion wire to mix and disperse a sclerosant on the vessel wall to cause ablation of a vein.

 

This technique has several advantages; unlike radiofrequency and laser therapy, ClariVein does not require tumescent anaesthesia, and can be used to treat near nerve bundles without concern for nerve damage, so the procedure is fast and essentially pain-free. The catheter is also fully disposable and a generator is not required, so the costs of operation and maintenance are eliminated.




Add New Comment

Most popular


First drug-eluting balloon approved in USA
Friday, 10 Oct 2014
The FDA has approved the Lutonix drug-eluting balloon for the management of peripheral artery disease. This is the first time that the agency has approved such a device for this indication in the USA. First drug-eluting balloon approved in USA

Live from VEITH 2014: SUPERB results show 94% freedom from reintervention with nominal deployment of Supera at three years
Wednesday, 19 Nov 2014
Three-year follow-up results of patients treated with the Supera stent show that nominal deployment or slight compression of the device delivers the best outcomes in terms of durability, and that ... Live from VEITH 2014: SUPERB results show 94% freedom from reintervention with nominal deployment of Supera at three years

Bioresorbable scaffolds can produce comparable acute results to metal stents
Tuesday, 04 Nov 2014
Speaking at the Asian Society for Vascular Surgery meeting (5–7 September, Hong Kong, China), Andrew Holden commented that studies indicate that bioresorbable scaffolds can produce comparable acute ... Bioresorbable scaffolds can produce comparable acute results to metal stents

Features


A new classification system for acute type B aortic dissection predicting reverse aortic remodelling
Wednesday, 19 Nov 2014
In recent years, primary stent grafting for complicated type B aortic dissection has been applied with favourable results. Thoracic aortic endovascular repair can be offered with a relatively low ... A new classification system for acute type B aortic dissection predicting reverse aortic remodelling

Resolving differences between carotid stenosis management guidelines
Wednesday, 19 Nov 2014
Anne Abbott, Melbroune, Australia, writes that while some variability in guideline recommendations is due to different publication dates, much is due to bias in what evidence is considered and how it ... Resolving differences between carotid stenosis management guidelines

Profiles


Martin Björck
Wednesday, 01 Oct 2014
Martin Björck, Uppsala University Hospital, Sweden, holds the only professor-chair of vascular ... Martin Björck

Cliff Shearman
Thursday, 03 Jul 2014
A former president of the Vascular Society of Great Britain and Ireland, Cliff Shearman was ... Cliff Shearman

Cardiac Rhythm News Vascular News Cardiovascular News Interventional News Spinal News NeuroNews
BIBA Medical BIBA MedTech Insights CX Symposium ilegx
 
Password Reminder

BIBA Medical, 526 Fulham Road, Fulham, London, SW6 5NR.
TEL: +44 (0)20 7736 8788 FAX: +44 (0)20 7736 8283 EMAIL: 
info@bibamedical.com
© BIBA Medical Ltd is a company registered in England and Wales with company number 2944429.
VAT registration number 730 6811 50.
Site Map | Terms and Conditions